Literature DB >> 32014945

Selection Criteria and Clinical Outcomes of Patients With Asymmetrical Cervical Cancer Treated With Various High-dose-rate Brachytherapy Techniques.

Keiko Nemoto Murofushi1,2, Yasuo Yoshioka3, Hitoshi Ishikawa2, Minako Sumi3, Toshiyuki Okumura2, Masahiko Oguchi3, Hideyuki Sakurai2.   

Abstract

BACKGROUND/AIM: We aimed to evaluate the efficacy of high-dose-rate brachytherapy techniques selected according to pre-brachytherapy magnetic resonance imaging (MRI) findings in asymmetrical cervical cancer (ACC). PATIENTS AND METHODS: We analyzed 33 ACC patients. Asymmetric tumors were defined as those in which the difference between the distance from the cervical canal to the farthest end of the tumor [long distance (LD)] and the distance from the cervical canal to the contralateral tumor edge [short distance (SD)] is equal to or greater than 2 cm on the basis of MRI prior to treatment. On pre-treatment and pre-brachytherapy MRI, the median LDs were 40 mm and 21 mm, respectively. Patients with LD≥2 cm and LD - SD≥1 cm on pre-brachytherapy MRI received non-conventional intracavitary brachytherapy (ICBT).
RESULTS: Sixteen patients (48%) received non-conventional ICBT. There was no significant difference in 3-year local control between the two treatment groups (100% vs. 81.2%, p=0.07); two patients had grade 2 radiation proctitis.
CONCLUSION: Brachytherapy techniques selected according to pre-brachytherapy MRI findings were effective for ACC treatment. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Cervical cancer; high-dose-rate brachytherapy; pre-brachytherapy magnetic resonance imaging; radiotherapy

Mesh:

Year:  2020        PMID: 32014945     DOI: 10.21873/anticanres.14034

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer.

Authors:  Yuki Mukai; Yumiko Minagawa; Hiromi Inoue; Akiko Sato; Kengo Matsui; Takanori Fukuda; Kazuya Onuma; Hideyuki Hongo; Ryosuke Shirata; Hironori Nagata; Harumitu Hashimoto; Tomio Inoue; Masaharu Hata; Motoko Omura
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 2.  A Ten-year-long Update on Radiation Proctitis Among Prostate Cancer Patients Treated With Curative External Beam Radiotherapy.

Authors:  Gianluca Ferini; Stefano Pergolizzi
Journal:  In Vivo       Date:  2021-04-28       Impact factor: 2.406

3.  Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy.

Authors:  Keiko Nemoto Murofushi; Toshiki Ishida; Keiichiro Baba; Kenji Kawakita; Tsukasa Saida Sasaki; Toshiyuki Okumura; Toyomi Sato; Hideyuki Sakurai
Journal:  J Contemp Brachytherapy       Date:  2021-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.